Studies of proopiomelanocortin (POMC) mutations showed an association between obesity in humans and a subsequent increase in the risk of obesity-related diseases, such as T1D and T2D [76,77]. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.